Related Experiment Video
Updated: Sep 17, 2026
07:34
Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
Published on: November 17, 2023
Challenges of Using Circulating Tumour DNA: Insights from Advanced Prostate Cancer
Tarek Taha1, Ossian Longoria1, Johann de Bono1
1The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK.
European Urology
|September 15, 2026
Abstract:
Precision oncology relies on integrating tumour fraction, variant allele frequency, clonal haematopoiesis of indeterminate potential assessment, pathogenicity, and clinical context into next-generation sequencing interpretation, enabling biologically informed and clinically meaningful treatment decisions while reducing the risk of overinterpreting nontumour or nonactionable genomic alterations.
